Ipsen: a gain of 50%…

Pharmaceuticals. In a troubled period, managers are regaining a taste for low-risk projects such as pharmaceuticals. These values ​​are in fact little impacted by the deterioration of the economic situation, the rise in interest rates, geopolitical disorders, the pressure on the purchasing power of households… Showing +25% since January 1, the Ipsen stock is a good example of this configuration favorable to the health sector. The stock is even at a 5-year high…